Embecta (EMBC) CEO On Helping Diabetes For 100 Years

Embecta (EMBC) is a global medical device company that focuses on providing solutions to people living with diabetes. CEO, Dev Kurdikar discusses the outlook for the company. He talks about how EMBC is one of the leading manufacturers of pen needles and he estimates that 30M people around the world use them. EMBC produces almost 8B units per year and the company has been in business for almost 100 years. He then goes over what's next for EMBC. Tune in to find out more about EMBC and the stock market today.

Morning Trade Live

01 Nov 2022

SHARE

ON AIR
1:00 am
Trading 360
replay
12:00 am
Fast Market
REPLAY
ON AIR
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now